|
Volumn 37, Issue 4, 2009, Pages 163-165
|
Hemoglobin-based oxygen carriers combined with anticancer drugs may enhance sensitivity of radiotherapy and chemotherapy to solid tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICANCER DRUG;
CLINICAL USE;
ENHANCED SENSITIVITY;
HEMOGLOBIN-BASED OXYGEN CARRIERS;
LIMITING FACTORS;
SOLID TUMORS;
TUMOR OXYGENATION;
TUMOR TREATMENT;
VASCULAR ARCHITECTURE;
BIOCHEMISTRY;
CHEMOTHERAPY;
HEMOGLOBIN;
ONCOLOGY;
OXYGEN;
OXYGENATION;
RADIOTHERAPY;
TUMORS;
ANTINEOPLASTIC AGENT;
DRUG CARRIER;
HEMOGLOBIN BASED OXYGEN CARRIER;
UNCLASSIFIED DRUG;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
DRUG DELIVERY SYSTEM;
DRUG RETENTION;
LIVER CANCER;
LUNG CANCER;
OXYGENATION;
RADIOSENSITIVITY;
SOLID TUMOR;
ANIMALS;
ANOXIA;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL TRANSPORT;
BLOOD SUBSTITUTES;
ERYTHROCYTES;
FEASIBILITY STUDIES;
HEMOGLOBINS;
HUMANS;
NEOPLASMS;
OXYGEN;
PARTICLE SIZE;
VISCOSITY;
|
EID: 68849086655
PISSN: 10731199
EISSN: 15324184
Source Type: Journal
DOI: 10.1080/10731190903043218 Document Type: Article |
Times cited : (38)
|
References (11)
|